| 产品详情 |
| Edit |   |
| Product Name | Recombinant Clostridium botulinum Botulinum neurotoxin type D |
| Description | 1-442. Partial, provide the Botulinum neurotoxin D light chain. MW: 52.54kD. Purity >90% as determined by SDS-PAGE. Botulinum toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that cleaves the '60-Lys-|-Leu-61' bond of synaptobrevins-1 and |
| Size | 0.01 mg (E-Coli), 0.01 mg (Yeast), 0.05 mg (E-Coli), 0.05 mg (Yeast), 0.1 mg (E-Coli) |
| Concentration | n/a |
| Applications | n/a |
| Other Names | [Bontoxilysin-D] |
| Gene, Accession, CAS # | botD, Accession: P19321.1 |
| Catalog # | MBS1119161 |
| Price | |
| Order / More Info | Recombinant Clostridium botulinum Botulinum neurotoxin type D from MYBIOSOURCE INC. |
| Product Specific References | Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D.Binz T., Kurazono H., Popoff M.R., Eklund M.W., Sakaguchi G., Kozaki S., Krieglstein K., Henschen A., Gill D.M., Niemann H.Nucleic Acids Res. 18:5556-5556(1990) The complete amino acid sequence of the Clostridium botulinum type D neurotoxin, deduced by nucleotide sequence analysis of the encoding phage d-16 phi genome.Sunagawa H., Ohyama T., Watanabe T., Inoue K.J. Vet. Med. Sci. 54:905-913(1992) Molecular diversity |
| 产品资料 |
|
|